日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A 3-(4-nitronaphthen-1-yl) amino-benzoate analog as a bifunctional AKR1C3 inhibitor and AR antagonist: Head to head comparison with other advanced AKR1C3 targeted therapeutics

3-(4-硝基萘-1-基)氨基苯甲酸酯类似物作为双功能 AKR1C3 抑制剂和 AR 拮抗剂:与其他先进的 AKR1C3 靶向疗法进行正面比较

Phumvadee Wangtrakuldee, Adegoke O Adeniji, Tianzhu Zang, Ling Duan, Buddha Khatri, Barry M Twenter, Michelle A Estrada, Tyler F Higgins, Jeffrey D Winkler, Trevor M Penning

Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer

含有N-(芳基)氨基苯甲酸酯抑制剂和双功能AKR1C3抑制剂/雄激素受体拮抗剂的AKR1C3晶体结构。去势抵抗性前列腺癌的治疗先导化合物

Chen, Mo; Adeniji, Adegoke O; Twenter, Barry M; Winkler, Jeffrey D; Christianson, David W; Penning, Trevor M

A NEW APPROACH TO THE SYNTHESIS OF SUBSTITUTED PHENAZINES VIA PALLADIUM-CATALYZED ARYL LIGATION(i)

通过钯催化芳基连接合成取代吩嗪的新方法(i)

Winkler, Jeffrey D; Twenter, Barry M; Gendrineau, Thomas

Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)

发现取代的 3-(苯氨基)苯甲酸是 5 型 17β-羟基类固醇脱氢酶 (AKR1C3) 的强效选择性抑制剂

Adeniji, Adegoke O; Twenter, Barry M; Byrns, Michael C; Jin, Yi; Winkler, Jeffrey D; Penning, Trevor M